Form D · Venture Capital Fund

Valence CDK SPV, L.P.

New York, NY · CIK 0001600038

Offering snapshot reported Mar 17, 2014 · SEC filing

Reported sold
$10.5M
Offering amount: $10.5M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 4, 2013
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 17, 2014Initial$10,500,000No comparison1SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.1
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-213734

Source: Form D, filed Mar 17, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

VALENCE CDK SPV, L.P.

Investment adviser: VALENCE LIFE SCIENCES, LLC

Gross asset value
$10.5M
Beneficial owners
5
ADV minimum commitment
$0

Reported in Form ADV on Feb 23, 2016. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Custodian PERSHING LLC JERSEY CITY, New Jersey, United States Related to adviser: No
Prime broker CREDIT SUISSE SECURITIES (USA) LLC NEW YORK, New York, United States
Provider details
Annual audit
No
Prime brokers
Yes
Custodians
Yes
Administrator other than the adviser
No
External marketing
No

PERSHING LLC
SEC 8-17574

CREDIT SUISSE SECURITIES (USA) LLC
CRD 816 · SEC 8-422

Filing source

Form ADV 979499 · Feb 23, 2016 · Schedule D 7.B.(1), fund 805-5928487217

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Eric Roberts Director
N/A Valence Life Sciences Gp Ii, Llc Director

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
500 Park Avenue, 9 Th Floor
New York, NY, 10022